ANTIPLATELET GPIIB/IIIA (7E3) ANTIBODY IN ELECTIVE PTCA - SAFETY AND INHIBITION OF PLATELET-FUNCTION

被引：0
|
作者：
ELLIS, SG [1 ]
NAVETTA, FI [1 ]
TCHENG, JT [1 ]
WEISMAN, HF [1 ]
WANG, AL [1 ]
PITT, B [1 ]
TOPOL, EJ [1 ]
机构：
[1] UNIV MICHIGAN,ANN ARBOR,MI 48109
来源：
CIRCULATION | 1990年 / 82卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [1] CHIMERIZATION OF MONOCLONAL-ANTIBODY 7E3 PRESERVES THE GPIIB/IIIA RECEPTOR BLOCKADE AND PLATELET FUNCTIONAL INHIBITION OF MURINE 7E3
    BHATTACHARYA, S
    WEISMAN, HF
    MORRIS, KG
    MILLER, MJ
    JORDAN, RE
    SENIOR, R
    SANE, DC
    MACKIE, I
    MACHIN, S
    LAHIRI, A
    CLINICAL RESEARCH, 1991, 39 (02): : A196 - A196
  • [2] BLOCKADE OF THE HUMAN PLATELET GPIIB/IIIA RECEPTOR BY A MURINE MONOCLONAL-ANTIBODY FAB FRAGMENT (7E3) - POTENT DOSE-DEPENDENT INHIBITION OF PLATELET-FUNCTION
    BHATTACHARYA, S
    JORDAN, R
    MACHIN, S
    SENIOR, R
    MACKIE, I
    SMITH, CR
    SCHAIBLE, TF
    WEISMAN, HF
    LAHIRI, A
    CARDIOVASCULAR DRUGS AND THERAPY, 1995, 9 (05) : 665 - 675
  • [3] INHIBITION OF PLATELET-AGGREGATION BY ANTIPLATELET GP IIB/IIIA (7E3) FAB MURINE MONOCLONAL-ANTIBODY - RELATIONSHIP TO DOSE
    BHATTACHARYA, S
    MACKIE, I
    MACHIN, S
    LEESE, P
    SCHAIBLE, T
    JORDAN, R
    SMITH, C
    BERGER, H
    LAHIRI, A
    CIRCULATION, 1990, 82 (04) : 602 - 602
  • [4] SAFETY AND ANTIPLATELET EFFECT OF MURINE MONOCLONAL-ANTIBODY 7E3 FAB DIRECTED AGAINST PLATELET GLYCOPROTEIN-IIB/IIIA IN PATIENTS UNDERGOING ELECTIVE CORONARY ANGIOPLASTY
    ELLIS, SG
    TCHENG, JE
    NAVETTA, FI
    MULLER, DWM
    WEISMAN, HF
    SMITH, C
    ANDERSON, KM
    CALIFF, RM
    TOPOL, EJ
    CORONARY ARTERY DISEASE, 1993, 4 (02) : 167 - 175
  • [5] INHIBITION OF PLATELET-AGGREGATION BY ANTIPLATELET GP-IIB-IIIA (7E3) FAB MURINE MONOCLONAL-ANTIBODY - RELATIONSHIP TO DOSE
    BHATTACHARYA, S
    MACKIE, I
    MACHIN, S
    LEESE, P
    SCHAIBLE, T
    JORDAN, R
    SMITH, C
    BERGER, H
    LAHIRI, A
    ARTERIOSCLEROSIS, 1990, 10 (05): : A910 - A910
  • [6] Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets
    Wagner, CL
    Mascelli, MA
    Neblock, DS
    Weisman, HF
    Coller, BS
    Jordan, RE
    BLOOD, 1996, 88 (03) : 907 - 914
  • [7] COMPARISON OF CLINICAL EFFICACY OF MURINE AND CHIMERIC 7E3 MONOCLONAL-ANTIBODIES ON PLATELET-FUNCTION
    MACHIN, SJ
    MACKIE, IJ
    FAINT, RW
    BHATTACHARYA, S
    LAHIRI, A
    JORDAN, R
    WEISMAN, HF
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1180 - 1180
  • [8] THE EFFECT OF A MONOCLONAL-ANTIBODY SPECIFIC FOR HUMAN-PLATELET GPIIB/IIIA (TP80) ON PLATELET-FUNCTION
    HIGASHIHARA, M
    MAEDA, H
    OHASHI, T
    OKA, H
    KUME, S
    ACTA HAEMATOLOGICA JAPONICA, 1987, 50 (04): : 926 - 935
  • [9] CONTRIBUTION OF PLATELETS AND THE VESSEL WALL TO THE ANTITHROMBOTIC EFFECTS OF A SINGLE BOLUS INJECTION OF FAB FRAGMENTS OF THE ANTIPLATELET GPIIB/IIIA ANTIBODY 7E3 IN A CANINE ARTERIAL EVERSION GRAFT PREPARATION
    KISS, RG
    STASSEN, JM
    DECKMYN, H
    ROSKAMS, T
    GOLD, HK
    PLOW, EF
    COLLEN, D
    ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (03): : 375 - 380
  • [10] Abciximab [7E3] pharmacodynamics demonstrates an extended and gradual recovery from GPIIb/IIIa blockade.
    Mascelli, MA
    Lance, ET
    Wagner, CL
    Weisman, HF
    Jordan, RE
    CIRCULATION, 1996, 94 (08) : 3008 - 3008
12345